0.07Open0.07Pre Close0 Volume230 Open Interest2.50Strike Price0.00Turnover282.83%IV142.45%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type0.2149Delta0.3734Gamma15.14Leverage Ratio-0.0046Theta0.0001Rho3.25Eff Leverage0.0008Vega
Cumberland Pharmaceuticals Stock Discussion
Cumberland Pharmaceuticals Receives FDA Orphan Drug and Rare Pediatric Disease Designations for New Treatment of Duchenne Muscular Dystrophy
$SNDL Inc (SNDL.US)$
$Cumberland Pharmaceuticals (CPIX.US)$
$Sonoma Pharmaceuticals (SNOA.US)$
$Ispire Technology (ISPR.US)$
$Veru Inc (VERU.US)$
$Greenlane (GNLN.US)$
$OrganiGram (OGI.US)$
$Cronos Group (CRON.US)$
$GrowGeneration (GRWG.US)$